Cannabinoid–Opioid Interaction in Chronic Pain

Abrams, D I, Couey, P, Shade, S B, Kelly, M E, Benowitz, N L·2011·Clinical Pharmacology & Therapeutics
DOI 10.1038/clpt.2011.188

Cited by (319)

Items 201–300 of 319

  1. Pharmacological Strategies to Decrease Long-Term Prescription Opioid Use: A Systematic Review
    Hannah Ellerbroek, Gerard Arnoldus Kalkman, Cornelis Kramers, Arnt Schellekens, Bart J. F. van den Bemt · 2024 · Journal of Clinical Medicine
  2. A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence
    Josée Guindon · 2016 · Neuropharmacology
  3. S-Lagrangian dynamics of many-body systems and behavior of social groups: Dominance and hierarchy formation
    Uziel Sandler · 2017 · Physica A Statistical Mechanics and its Applications
  4. Mitigating potential public health problems associated with edible cannabis products through adequate regulation: A landscape analysis
    Aurash J Soroosh, Robin Henderson, Lori Dodson, Clifford S. Mitchell, Jed W. Fahey · 2020 · Critical Reviews in Food Science and Nutrition
  5. Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain
    Joren Manz, Momoe Hyakutake, Erin Kelly · 2020 · Journal of Obstetrics and Gynaecology Canada
  6. Cannabinoids‐Human Physiology and Agronomic Principles for Production
    Robert Arthur Williams, David W. Williams · 2019 · ASSA, CSSA and SSSA
  7. Effect of cannabis use history on postoperative opioid utilization in lumbar fusion patients: an American retrospective study
    Pranav Mirpuri, Syed Ibad Khalid, Patrick King, Joanna Mary Roy, Aladine A. Elsamadicy, Ankit Indravadan Mehta, Owoicho Adogwa · 2024 · Asian Spine Journal
  8. Role of the Endocannabinoid System in Fibromyalgia
    Mario García‐Domínguez · 2025 · Current Issues in Molecular Biology
  9. Cannabis Use Among Cancer Patients During Active Treatment: Findings From a Study at an NCI ‐Designated Cancer Center
    Amrit Baral, Bria-Necole Diggs, Ranya Marrakchi El Fellah, Connor McCarley, Frank J. Penedo, Claudia Martinez, Denise Christina Vidot · 2024 · Cancer Medicine
  10. Acute kappa opioid receptor blocking disrupts the pro-cognitive effect of cannabidiol in neuropathic rats
    Serena Boccella, Antimo Fusco, Federica Ricciardi, Andrea Maria Morace, Roozbe Bonsale, Michela Perrone, Ida Marabese, Danilo De Gregorio, Carmela Belardo, Luca Posa et al. · 2024 · Neuropharmacology
  11. Medical Marijuana in Pediatric Neurological Disorders
    Anup D. Patel · 2015 · Journal of Child Neurology
  12. Clearing the Smoke Around Medical Marijuana
    Mark A. Ware · 2011 · Clinical Pharmacology & Therapeutics
  13. Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors
    Yoshinori Takemura, Yuka Sudo, Tomoya Saeki, Shinji Kurata, Tsutomu Suzuki, Tomohisa Mori, Yasuhito Uezono · 2022 · Journal of Pharmacological Sciences
  14. Use and Perceptions of Opioids versus Marijuana among People Living with HIV
    Jessica M. Potts, Betelihem Getachew, Milkie Vu, Eric J. Nehl, Katherine A. Yeager, Carla J. Berg · 2020 · American Journal of Health Behavior
  15. Social work and medical students' perspectives on the use of cannabis as a medical intervention
    Jennifer B. Cogswell, Susan Harris · 2015 · John Spoor Broome Library Institutional Repository (California State University)
  16. Tetrahydrocannabinol – friend or foe? – Debate
    Leslie Mendoza Temple, Jerrold Blair Leikin · 2019 · Clinical Toxicology
  17. Smokeless consumption of medical cannabis pharmacokinetics, safety and feasibility of the CannaHALER© a phase 1a study
    Offir Ben‐Ishay, Ortal Bar-On, Yoram S Kluger · 2020 · Journal of Cannabis Research
  18. Efficacy of pain management strategies in adults with Amyotrophic Lateral Sclerosis (ALS): A Systematic Review
    Juan Camilo Rojas-López, Pablo Isaac Estrada-Gualdron, Sofía Ramírez-Guerrero, Maria J. Velásquez-Cárdenas, Jesús Redondo-Escobar, Sofía Vargas-Arenas, Leonardo Palacios-Sánchez, Ximena Palacios‐Espinosa · 2024 · Neurological Sciences
  19. Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review
    Cecilia Maldonado, Raquel Peyraube, Pietro L. Fagiolino, Florencia Oricchio, Leticia Cuñetti, Marta Vázquez · 2024 · Current Pharmaceutical Design
  20. Bhanga as an activity potentiater in Ayurvedic classics and Indian alchemy (Rasashastra): A critical review
    Swagata Dilip Tavhare, Rabinarayan Acharya · 2016 · International Journal of Ayurvedic Medicine
  21. The Fallacy of a One Size Fits All Cannabis Policy
    Amanda Reiman · 2022 · Humboldt Journal of Social Relations
  22. The Role of Cannabinoids in Chronic Pain Patients Remains Hazy
    Bojin Chen, Robert S. Hoffman · 2012 · Clinical Pharmacology & Therapeutics
  23. Practical Recommendations for the Use of Medical Cannabis
    Maria Fernanda Arboleda, Erin Prosk · 2021 · Springer eBooks
  24. Medical Marijuana for Pain Management in Hospice Care as a Complementary Approach to Scheduled Opioids: A Single Arm Study
    Theodore Zanker, Joseph Sacco, James Prota, Michelle Palma, Kyoung A Viola Lee, Ruixiao Rachel Wang, Yixuan Liang, James C. Cunningham, Mona Mackary, Polina Ovchinnikova · 2023 · American Journal of Hospice and Palliative Medicine®
  25. The Endocannabinoid System in Local and Systemic Inflammation
    Melanie E. M. Kelly, Christine Lehmann, Juan Zhou · 2017 · Colloquium Series on Integrated Systems Physiology From Molecule to Function
  26. Baseline Cannabinoid Use Is Associated with Increased Sedation Requirements for Outpatient Endoscopy
    Yasmin Nasser, Soliman Biala, Millie Chau, Arun C.R. Partridge, Jeong Yun Yang, Brendan Cord Lethebe, Laura M. Stinton, Mohan Cooray, Martin J. Cole, Christopher Ma et al. · 2022 · Cannabis and Cannabinoid Research
  27. Association of cannabis and/or opioid with quality of life and healthcare utilization in patients with chronic pain
    Vafi Salmasi, Lorene M. Nelson, Juliette S. Hong, Sean Mackey · 2022 · Frontiers in Pain Research
  28. Drug interactions with Cannabis sativa: Mechanisms and clinical implication
    Atena Hasanpoor, Maryam Akaberi, Prashant Kesharwani, Zahra Sobhani, Amirhossein Sahebkar · 2023 · Annales de Toxicologie Analytique
  29. 3,3-Dibromoflavanone, a synthetic flavonoid derivative for pain management with antidepressant-like effects and fewer side effects than those of morphine in mice
    Natalia Claudia Colettis, Josefina Higgs, Cristina Wasowski, Damijan Knez, Stanislav Gobec, Valentina Pastore, Mariel Marder · 2024 · Chemico-Biological Interactions
  30. Medical marijuana in cancer: harmful or harm reduction?
    Alexandra Thielmann, Paul Joseph Daeninck · 2013 · Clinical Practice
  31. Cannabis en el tratamiento del dolor crónico no oncológico
    Evelyn Muñoz S. · 2015 · Revista Hospital Clínico Universidad de Chile
  32. Cannabis Drug Interactions
    George Polson, Matthew J. Chung, Salman Hirani, Christina Le-Short · 2021 · Springer eBooks
  33. Cannabis and Cannabinoids (PDQ
    Pdq Integrative · 2011
  34. Complementary and Alternative (CAM) Treatment Options for Women with Pelvic Pain
    Malathy Srinivasan, Joseph E. Torres, Donald D. McGeary, Ameet Nagpal · 2020 · Current Physical Medicine and Rehabilitation Reports
  35. The role of cannabinoids in the management of symptoms in palliative care patients
    Michał Graczyk, Wojciech Leppert · 2021 · Palliative Medicine in Practice
  36. Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference
    Amie J. Goodin, Debbie L. Wilson, Robert L. Cook, Yan Wang, Joshua David Brown, Almut Gertrud Winterstein · 2021 · Medical Cannabis and Cannabinoids
  37. The Interaction of Opiate Misuse and Marijuana Use on Behavioral Health Outcomes Using the Traumatic Brain Injury Model Systems Pain Collaborative Dataset
    Librada Callender, Tony Lai, Simon J. Driver, Jessica McKinney Ketchum, Christa Ochoa, John D. Corrigan, Flora M. Hammond, Cindy Harrison-Felix, Aaron M. Martin, Amanda R. Rabinowitz et al. · 2024 · Journal of Head Trauma Rehabilitation
  38. Pharmacodynamic effects following co-administration of cannabinoids and opioids: a scoping review of human experimental studies
    David Guy, Jared C Wootten, Michael Wong, Daniel Turski, Mark K. Lukewich, Abdulrahman S. Alboog, Abirami R. Kandasamy, Jonathan Gregory, Raju Poolacherla · 2024 · Pain Medicine
  39. Additive antinociceptive action of intrathecal anandamide reuptake inhibitor and morphine in the management of post-incisional pain in rats
    Antonio J. Carrascosa, María S. García‐Gutiérrez, Raquel Saldaña, Jorge Manzanares · 2024 · Biomedicine & Pharmacotherapy
  40. Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?
    Benjamin Malcolm, Laura L. Murphy, Michael Wong (Con) · 2018 · The Canadian Journal of Hospital Pharmacy
  41. Reduced Urinary Opioid Levels from Pain Management Patients Associated with Marijuana Use
    Melissa M. Goggin, Breane J Shahriar, A. H. Stead, Gregory C. Janis · 2019 · Pain Management
  42. Complementary and Alternative Medicine
    Jeffrey D. White · 2020 · Elsevier eBooks
  43. Repeated Administration of the Cannabinoid WIN Alters the Isoflurane-Sparing Effect of Morphine and Dexmedetomidine
    José Antonio Ibancovichi-Camarillo, Julio Raúl Chávez-Monteagudo, Pedro Sánchez-Aparicio, Marco Antonio De Paz-Campos · 2023 · Veterinary Sciences
  44. Impact of Low-Dose Dronabinol Therapy on Cognitive Function in Cancer Patients Receiving Palliative Care: A Case-Series Intervention Study
    Ditte Buchwald, Casper Schmidt, Dorte Buchwald, Kristina Iris Winter, Ivan Bo Nielsen, Kirsten Klostergaard, Dorte Melgaard, Steen Kåre Fagerberg, Peter Derek Christian Leutscher · 2023 · Palliative Medicine Reports
  45. Beneficio clínico del tratamiento con cannabinoides para el dolor crónico no oncológico
    Julia Galzerano, María Daniela Ríos Pérez, Pablo Mariano Velázquez · 2023 · Revista Médica del Uruguay
  46. Evaluation of pre-hospital cannabis exposure and hospital opioid utilization in a trauma population: A retrospective cohort
    Alexander J. Chang, Ali F. Mallat, Marc J Edwards, Joseph N. Gabra, Michaelia D. Cucci · 2023 · Injury
  47. Hochdosisdronabinoltherapie vs. Medizinalcannabisblüten
    Christoph Wendelmuth, Knud Gastmeier · 2019 · Der Schmerz
  48. Livingston et al. Respond
    Melvin D. Livingston, Tracey E. Barnett, Chris Delcher, Alexander C. Wagenaar · 2018 · American Journal of Public Health
  49. Use of hemp extracts rich in THC and CBD in the chronic pain management
    Michał Graczyk, Łukasz Pawlak, Agata Lewandowska · 2024 · Medycyna Paliatywna
  50. Long-Term Inhaled Cannabis Therapy for Chronic Low Back Pain: A Five-Year Retrospective Analysis of Prospectively Collected Patient-Reported Outcomes in 241 Treatment-Refractory Patients
    Dror Robinson, Muhammad Khatib, Eitan Lavon, Niv Kafri, Waseem Abu Rashed, Hamza Murad, Mustafa Yassin · 2026 · Biomedicines
  51. Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone
    Friederike Amann, Gudrun Hefner, Peter Cremer-Schaeffer, Gerhard Gründer, Winfried Häuser, Xenia Marlene Hart, Frank W. Petzke, Gerald Zernig, Ursula Havemann‐Reinecke · 2026 · Pharmacopsychiatry
  52. The Management of Neuropathic Pain
    Cory Toth, Dwight E. Moulin · 2013 · Cambridge University Press eBooks
  53. Cómo responder al paciente con cáncer avanzado que nos plantea el uso de cannabis como tratamiento sintomático
    Álvaro Sanz Rubiales, Maku Zudaire, Begoña Morejón, Virginia de la Cruz, Itziar Gardeazábal, José María López-Picazo, María Luisa del Valle, Carlos Centeno · 2013 · Medicina Paliativa
  54. Adverse effects and Drug Interactions Associated with Inhaled Recreational and Medical Marijuana
    Maisha Kelly Freeman, Pilar Z Murphy · 2016 · INNOVATIONS in pharmacy
  55. Cannabis: A Review of the Good and the Bad
    Elizabeth A. M. Frost · 2018 · Topics in Pain Management
  56. The Therapeutic Potential of Cannabis and the Endocannabinoid System
    Linda E. Klumpers, Arno Hazekamp · 2019 · CRC Press eBooks
  57. Cannabis in Oncology and Symptom Management
    Matthew J. Chung, Salahadin Abdi · 2020 · Springer eBooks
  58. Cannabis-drug interactions: Implications for medicinal cannabis use
    Fran M. Gengo, Anna G. Mattle, Christopher C. Ralyea · 2023 · Elsevier eBooks
  59. Natural Products Derived from Cannabis sativa for Pain Management
    Erika Liktor‐Busa, Tally M. Largent‐Milnes · 2024 · Handbook of experimental pharmacology
  60. Implications of cannabis legalization for the US federal budget
    Alex Brill, Brian J. Miller, Stan A. Veuger · 2024 · Public Budgeting &amp Finance
  61. Recreational Drugs Repurposed for Medicinal Use – Cannabis
    Mike Armour, Justin Sinclair, Hannah Adler · 2025 · Cambridge University Press eBooks
  62. Medical cannabis authorization and opioid milligram equivalents over time in patients with chronic pain: a retrospective analysis
    Michelle Sexton, Nicholas C. Glodosky, Michael John Cleveland, Carrie Cuttler, Euyhyun Lee, Gregory R. Polston, Timothy J. Furnish, Imanuel R. Lerman, Nathaniel M. Schuster, Mark S. Wallace · 2025 · Pain Medicine
  63. Cannabis and Synthetic Cannabinoids for Cancer Patients: Multiple Palliative Indications Together With Promising Laboratory Antineoplastic Effects
    Daniela Zalman, Gil Bar‐Sela · 2017 · Elsevier eBooks
  64. Complementary and Integrative Therapies in Palliative Care
    Mary-Anne Meyer, Melinda R. Ring · 2019
  65. Lagrangian fuzzy dynamics and behavior of living beings in the environment: Peace, war and ecological catastrophes
    Uziel Sandler · 2019 · Physica A Statistical Mechanics and its Applications
  66. Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis
    Assad Hayat, Brian J. Piper · 2019 · Journal of Psychoactive Drugs
  67. Cannabinoids: The Case for Legal Regulation That Permits Recreational Adult Use
    Tiesha T. Gregory, Kate Y. O’Malley, Christopher Medina-Kirchner, Marc Grifell, Carl L. Hart · 2022 · Springer eBooks
  68. Perinatal cannabis exposure and long-term consequences on synaptic programming
    Gabriele Giua, Olivier J. Manzoni, Andrew F. Scheyer · 2022 · Elsevier eBooks
  69. Prescribing Controlled Prescription Medications: Special Considerations
    Alicia Potter DeFalco, Michael G. O’Neil · 2019 · Journal of the California Dental Association
  70. Cannabinoids and the brain: New hopes for new therapies
    Javier Fernández‐Ruíz, Mariluz Hernández, Yolanda García‐Movellán · 2014 · Wiley eBooks
  71. The Current Landscape of Marijuana and Pharmacogenetics
    Kerry Anne Rambaran, Michael Chu, Tyler B. Johnson, Saeed K Alzghari · 2017 · Cureus
  72. Pain Management for the Emergency and Critical Care Patient
    Alison J. Gottlieb · 2018
  73. Long-Term Effectiveness, Psychiatric Distress, and Chronic Pain in Opioid-Dependent Individuals Receiving Treatment with Extended-Release Naltrexone
    Zill-E-Huma Latif · 2019 · NORA - Norwegian Open Research Archives
  74. Localization of cb1 receptors in rat`s periaqueductal gray after immobilization stress and effects of peptide tyr-w-mif- 1. immunocytochemical study
    Lina G. Malinova, Hristina Nocheva, Adriana I. Bocheva, Boycho V. Landzhov, Elena Dzambazova, Anastasia Bozhilova-Pastirova · 2015 · Scripta Scientifica Medica
  75. Inflammatory pain models with capsaicin or glutamate injections: Are they comparable and reproducible?
    Josée Guindon, Jian‐Sheng Lin · 2014 · Clinical and Experimental Pharmacology and Physiology
  76. Nabilone in inflammatory pain: to be or not to be
    Josée Guindon · 2012 · Clinical and Experimental Pharmacology and Physiology
  77. Cannabinoids
    Mark A. Ware · 2013 · Cambridge University Press eBooks
  78. Assessing and Treating Co-occurring Substance Abuse
    Jyothsna Karlapalem, Monica L. Broderick · 2016 · Springer eBooks
  79. Re: Cannabis som medisin
    Brage Wollnick · 2015 · Tidsskrift for Den norske legeforening
  80. Cannabis and analgesia
    Amine Benyamina, Lisa Blecha · 2012
  81. Research Article A study of the neurotoxic effects of tramadol and cannabis in adolescent male albino rats
    Ola Elsayed Nafea, Iman Elkhishin, Othman A. Awad, Dalia A. Mohamed · 2016
  82. Medical Marijuana Issue Complicated by Scientific, Political, And Regulatory Uncertainties
    Anne Haddad · 2017 · Topics in Pain Management
  83. Acute Perioperative Pain Management in Total Joint Arthroplasty: Summary of Available Agents
    Lopa Misra · 2017 · Topics in Pain Management
  84. Marijuana ades fins medicales: reflexions pour l'anesthesiologiste et le medecin specialiste de la douleur
    Pierre Beaulieu, Aline Boulanger, Julie Desroches, Alexander John Clark · 2016
  85. Mina tratatzeko estrategia farmakologiko berriak: kannabinoideak
    Erik Aostri, Joseba Pineda, Aitziber Mendiguren · 2017 · Osagaiz osasun-zientzien aldizkaria
  86. In consideration of cannabis
    Amanda Reiman · 2018 · Drug and Alcohol Review
  87. Pacientes que usan Cannabis sativa sp. con fines medicinales en Cuidados Paliativos, Hospital Gustavo Fricke: Resultados de una encuesta local
    Diego Eguren, José Cáceres, Silvana Misseroni · 2018 · Revista Chilena de Salud Pública
  88. Essays on Medical Marijuana Laws, Health Insurance and Health Care Utilization
    Pelin Ozluk · 2022 · Digital Archive @ GSU
  89. Opioid mortality following implementation of medical marijuana programs (1999-2017) in the United States
    Daniel E. Kaufman, Asawer M. Nihal, Janan D. Leppo, Kelly M. Staples, Kenneth L. McCall, Brian J. Piper · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Renal and Cardiovascular Outcomes Associated with Cannabis Use in Veterans with Advanced Chronic Kidney Disease Transitioning to Dialysis
    Praveen Kumar Potukuchi · 2020
  91. Имат ли място канабиноидите в лечението на ревматологични и автоимунни заболявания?
    Р. Каралилова, Лили Едвард Мекенян, Zguro Batalov, Таня Любомирова Сапунджиева · 2020 · Rheumatology (Bulgaria)
  92. Current and Future Uses of Medical Cannabis for Adults
    Sherry Yafai · 2020 · Routledge eBooks
  93. Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence
    Caroline A. MacCallum, Lauren de Freitas, Lauren Eadie, Samer Narouze · 2021 · Springer eBooks
  94. Medical Cannabis in Chronic Pain Management – Where Are We Now?
    Shamim Haider, WanJane Liew · 2021 · Indian Journal of Pain
  95. A New Ache in The World of Joints
    Teresa A. Simon · 2021 · Archives of Rheumatology & Arthritis Research
  96. Role of Cannabinoids in Pain Management
    Ethan B. Russo, Andrea G. Hohmann · 2014 · Springer eBooks
  97. A review of the evidence surrounding the safety of medical marijuana authorization for adults with neuropathic pain in primary care
    Michelle Ambrose · 2014
  98. Marijuana
    Greta Nemergut · 2019 · Springer eBooks
  99. Faculty Opinions recommendation of Cannabis use and risk of prescription opioid use disorder in the united states.
    Bernard Le Foll · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  100. Full Issue
    2022 · Humboldt Journal of Social Relations